Advocacy Announcement: ALS Disability Insurance Access Act

lesturnerAdvocacy, Foundation Blog, Home Page

Foundation Blog: Advocacy The Les Turner ALS Foundation has joined with several other national ALS patient advocacy organizations (ALS Association, I AM ALS, Muscular Dystrophy Association and Team Gleason) in a letter to U.S. House of Representatives’ leadership requesting that …

Data from Amylyx’s CENTAUR trial shows promise in slowing ALS progression

lesturnerClinical Trials, Foundation Blog, Home Page, Research News

We are very pleased to share promising data published this week in the New England Journal of Medicine from the recent CENTAUR trial, conducted by Amylyx Pharmaceuticals, showing that AMX0035, the combination drug of sodium phenylbutyrate–taurursodiol, can slow functional decline …